We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+14.03%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$5.25B
AUM Growth
+$2.55B
Cap. Flow
+$1.83B
Cap. Flow %
34.94%
Top 10 Hldgs %
32.08%
Holding
1,322
New
459
Increased
205
Reduced
157
Closed
337

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$19.5M
2
BYND icon
Beyond Meat
BYND
+$7.54M
3
RUN icon
Sunrun
RUN
+$7.26M
4
AMCX icon
AMC Global Media
AMCX
+$5.07M
5
QRVO icon
Qorvo
QRVO
+$4.19M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 7.87%
2 Communication Services 0.75%
3 Technology 0.67%
4 Healthcare 0.67%
5 Industrials 0.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
801
Wave Life Sciences
WVE
$1.12B
$324K 0.01%
+41,141
New +$345K
VIHAU
802
DELISTED
VPC Impact Acquisition Holdings Unit
VIHAU
$321K 0.01%
30,000
-20,000
-40% -$202K
FLR icon
803
CALL
Fluor
FLR
$6.54B
$319K 0.01%
+20,000
New +$283K
AAL icon
804
CALL
American Airlines Group
AAL
$9.82B
$315K 0.01%
20,000
ADEA icon
805
Adeia
ADEA
$2.55B
$314K 0.01%
56,700
+18,900
+50% +$82K
AIV
806
PUT
Aimco
AIV
$377M
$312K 0.01%
+59,000
New +$262K
CYTK icon
807
CALL
Cytokinetics
CYTK
$10.6B
$312K 0.01%
15,000
-194,200
-93% -$3.55M
SGMO
808
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$312K 0.01%
20,000
SGMO
809
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$312K 0.01%
20,000
EXEL icon
810
CALL
Exelixis
EXEL
$13.9B
$301K 0.01%
+15,000
New +$314K
EXEL icon
811
PUT
Exelixis
EXEL
$13.9B
$301K 0.01%
+15,000
New +$314K
NKTR icon
812
PUT
Nektar Therapeutics
NKTR
$2.39B
$298K 0.01%
1,167
-166
-12% -$42.9K
STNG icon
813
Scorpio Tankers
STNG
$3.91B
$297K 0.01%
26,500
TRIL
814
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
$294K 0.01%
+20,000
New +$288K
WPX
815
DELISTED
WPX Energy, Inc.
WPX
$292K 0.01%
+35,800
New +$228K
XPEV icon
816
XPeng
XPEV
$12.5B
$289K 0.01%
+6,750
New +$248K
TREB.U
817
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
$289K 0.01%
+25,000
New +$266K
WMT icon
818
Walmart Inc
WMT
$909B
$288K 0.01%
6,000
-69,000
-92% -$3.35M
OMER icon
819
CALL
Omeros
OMER
$845M
$286K 0.01%
20,000
-84,300
-81% -$1.03M
FISV
820
Fiserv Inc
FISV
$29.7B
$285K 0.01%
2,500
-17,500
-88% -$1.89M
CROX icon
821
PUT
Crocs
CROX
$6.63B
$276K 0.01%
4,400
B
822
CALL
Barrick Mining
B
$60.9B
$273K 0.01%
12,000
-1,000
-8% -$25.3K
CAH icon
823
PUT
Cardinal Health
CAH
$53.7B
$268K 0.01%
5,000
AUY
824
DELISTED
Yamana Gold, Inc.
AUY
$268K 0.01%
47,000
RIGL icon
825
PUT
Rigel Pharmaceuticals
RIGL
$723M
$263K 0.01%
7,500
+3,750
+100% +$109K

Similar funds

SG3 Management's Q4 2020 Portfolio in Review

As of Q4 2020, SG3 Management held 1,322 positions worth $5.25B, up 94% from $2.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

SG3 Management deployed $1.83B of net new capital in Q4 2020, opening 459 new positions and adding to 205 existing holdings. Its largest new stake was Amazon: 1,806,000 shares worth $294M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 7.9% of assets, up from 0.97% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $19.5M trimmed.

  • SG3 Management's largest Q4 2020 buy was Amazon: 1,806,000 shares worth $294M.
  • SG3 Management added most to Lennar Class A in Q4 2020, an estimated $66.8M increase.
  • SG3 Management's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $19.5M.
  • SG3 Management fully exited Beyond Meat in Q4 2020, selling an estimated $7.54M.
  • SG3 Management's ten largest holdings make up 32% of its $5.25B portfolio in Q4 2020.
  • SG3 Management opened 459 new positions and closed 337 in Q4 2020.
  • SG3 Management's portfolio value rose 94% quarter-over-quarter to $5.25B.

Based on SG3 Management's 13F filing for Q4 2020, filed 16 Feb 2021.